About Enhancer
Enhancer ID: |
E_01_0943 |
Species: |
human |
Position :
|
chr8:101489497-101491497 |
Biosample name: |
|
Experiment class :
|
High+Lowthroughput |
Enhancer type: |
Enhancer |
Disease: |
Gastric cancer |
Pubmed ID: |
32660626
|
Enhancer experiment: |
chromatin immunoprecipitation |
Enhancer experiment description: |
Expression of miR-130b-3p and GRHL2 was quantified in 63 pairs of cancerous and noncancerous gastric tissues. |
About Target gene
Target gene : |
-- |
Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: |
RNA-Seq |
Target gene experiment description: |
Expression of miR-130b-3p and GRHL2 was quantified in 63 pairs of cancerous and noncancerous gastric tissues. |
About TF
TF name : |
GRHL2(0610015A08Rik,BOM,Tcfcp2l3,clft3) |
TF experiment: |
chromatin immunoprecipitation |
TF experiment description: |
Expression of miR-130b-3p and GRHL2 was quantified in 63 pairs of cancerous and noncancerous gastric tissues. |
About Function
Enhancer function : |
Expression of miR-130b-3p and GRHL2 was quantified in 63 pairs of cancerous and noncancerous gastric tissues. |
Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function experiment description: |
Expression of miR-130b-3p and GRHL2 was quantified in 63 pairs of cancerous and noncancerous gastric tissues. |
About SNP
Upstream Pathway Annotation of TF
GeneName |
Pathway Name |
Source |
Gene Number |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs